Francesco Del Galdo MD PhD
Lead for Scleroderma Diagnostics, NIHR Diagnostic Evidence Co-operative Leeds


Dr Del Galdo joined the University of Leeds in 2009 as Senior Translational Research fellow and he is currently leading the Scleroderma Programme within Leeds Institute of Rheumatic and Musculoskeletal Medicine and the NIHR Leeds Musculoskeletal Biomedical Research Unit. The Scleroderma Programme comprises clinical, translational and basic research all focused on improving the understanding and ultimately the clinical management of Systemic Sclerosis. Working within the DEC, Dr Del Galdo has secured >£1m in funding from NIHR and MRC to further biomarker knowledge towards clinical adoption in Scleroderma. Specifically, the biomarker research of the Scleroderma Programme aims to identify reliable outcome measures of disease activity and to model a composite index predictive of severe organ involvement in patients affected or at risk of developing Scleroderma.